当前位置:首页 - 行情中心 - 荣昌生物(688331) - 财务分析 - 现金流量表

荣昌生物

(688331)

  

流通市值:157.39亿  总市值:546.57亿
流通股本:1.62亿   总股本:5.64亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,229,797,482.861,062,768,898.97475,062,495.731,496,544,541.19
  收到的税费返还3,199.683,199.681,051,545.2214,123,058.44
  收到其他与经营活动有关的现金26,135,188.3314,811,572.273,885,843.42121,832,252.34
  经营活动现金流入小计2,255,935,870.871,077,583,670.92479,999,884.371,632,499,851.97
  购买商品、接受劳务支付的现金104,074,192.6352,300,717.4613,281,935.21143,134,491.15
  支付给职工以及为职工支付的现金776,054,088.56531,384,544.56280,175,888.451,085,094,453.63
  支付的各项税费106,451,519.8676,394,469.6441,460,861.0674,347,927.98
  支付其他与经营活动有关的现金1,052,298,635.88663,043,194.53333,396,332.731,444,226,492.41
  经营活动现金流出小计2,038,878,436.931,323,122,926.19668,315,017.452,746,803,365.17
  经营活动产生的现金流量净额217,057,433.94-245,539,255.27-188,315,133.08-1,114,303,513.2
二、投资活动产生的现金流量:
  收回投资收到的现金1,050,000,000250,000,000150,000,0001,000,000,000
  取得投资收益收到的现金1,606,295.09661,791.67177,6252,601,249.99
  处置固定资产、无形资产和其他长期资产收回的现金净额1,610,219.631,414,066.7395,0007,201,197.61
  收到的其他与投资活动有关的现金9,578,4009,578,4009,578,40013,994,347.44
  投资活动现金流入小计1,062,794,914.72261,654,258.4159,851,0251,023,796,795.04
  购建固定资产、无形资产和其他长期资产支付的现金175,212,674.86120,552,809.8135,638,909.83265,281,866.7
  投资支付的现金1,167,127,956.2260,151,268.45151,000,0001,006,750,000
  投资活动现金流出小计1,342,340,631.06380,704,078.26186,638,909.831,272,031,866.7
  投资活动产生的现金流量净额-279,545,716.34-119,049,819.86-26,787,884.83-248,235,071.66
三、筹资活动产生的现金流量:
  吸收投资收到的现金783,623,475.65774,817,264.93232,945.361,032,897.91
  取得借款收到的现金1,333,647,815.421,198,221,840.57530,463,578.441,804,572,341.41
  收到其他与筹资活动有关的现金-1,836,362.93--
  筹资活动现金流入小计2,117,271,291.071,974,875,468.43530,696,523.81,805,605,239.32
  偿还债务支付的现金1,630,099,036.421,018,225,763.78316,006,600.73257,688,039.44
  分配股利、利润或偿付利息支付的现金66,397,042.9141,858,938.5723,994,702.4269,826,300.84
  支付其他与筹资活动有关的现金49,806,464.4134,454,700.6313,971,255.6285,122,094.96
  筹资活动现金流出小计1,746,302,543.741,094,539,402.98353,972,558.77412,636,435.24
  筹资活动产生的现金流量净额370,968,747.33880,336,065.45176,723,965.031,392,968,804.08
四、汇率变动对现金及现金等价物的影响-620,373.83-4,276,762.99-2,367,997.432,547,892.84
五、现金及现金等价物净增加额307,860,091.1511,470,227.33-40,747,050.3132,978,112.06
  加:期初现金及现金等价物余额759,530,043.42759,530,043.42759,530,043.42726,551,931.36
  期末现金及现金等价物余额1,067,390,134.521,271,000,270.75718,782,993.11759,530,043.42
补充资料:
  净利润--449,568,663.07--1,468,360,802.55
  资产减值准备---9,555,364.02
  固定资产和投资性房地产折旧-125,411,013.43-228,508,218.18
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-125,411,013.43-228,508,218.18
  无形资产摊销-4,149,416.39-7,538,995.87
  长期待摊费用摊销-2,001,255.77-5,584,443.58
  待摊费用的减少---1,184,445.13
  处置固定资产、无形资产和其他长期资产的损失--178,554.91-704,096.08
  固定资产报废损失-48,950.98-225,093.39
  公允价值变动损失--52,149.71--1,537,475.88
  财务费用-45,927,831.76-71,281,059.57
  投资损失-4,433,931.62--2,404,171.3
  存货的减少-18,121,441.28-72,384,239.6
  经营性应收项目的减少-56,657,676.2--333,326,264.25
  经营性应付项目的增加--91,496,853.28-152,463,841.12
  其他-12,139,512.52--
  现金的期末余额-1,271,000,270.75-759,530,043.42
  减:现金的期初余额-759,530,043.42-726,551,931.36
  现金及现金等价物的净增加额-511,470,227.33-32,978,112.06
公告日期2025-10-312025-08-232025-04-292025-03-28
审计意见(境内)标准无保留意见
TOP↑